342 related articles for article (PubMed ID: 26203166)
1. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.
Camporez JP; Asrih M; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Jornayvaz FR
J Endocrinol; 2015 Sep; 226(3):207-17. PubMed ID: 26203166
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
3. Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet.
Murata Y; Nishio K; Mochiyama T; Konishi M; Shimada M; Ohta H; Itoh N
PLoS One; 2013; 8(7):e69330. PubMed ID: 23874946
[TBL] [Abstract][Full Text] [Related]
4. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
[TBL] [Abstract][Full Text] [Related]
5. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
6. FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.
Liang Q; Zhong L; Zhang J; Wang Y; Bornstein SR; Triggle CR; Ding H; Lam KS; Xu A
Diabetes; 2014 Dec; 63(12):4064-75. PubMed ID: 25024372
[TBL] [Abstract][Full Text] [Related]
7. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
[TBL] [Abstract][Full Text] [Related]
8. Interplay between FGF21 and insulin action in the liver regulates metabolism.
Emanuelli B; Vienberg SG; Smyth G; Cheng C; Stanford KI; Arumugam M; Michael MD; Adams AC; Kharitonenkov A; Kahn CR
J Clin Invest; 2014 Feb; 124(2):515-27. PubMed ID: 24401271
[TBL] [Abstract][Full Text] [Related]
9. DEPP/DEPP1/C10ORF10 regulates hepatic glucose and fat metabolism partly via ROS-induced FGF21.
Li W; Ji M; Lin Y; Miao Y; Chen S; Li H
FASEB J; 2018 Oct; 32(10):5459-5469. PubMed ID: 29702025
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.
Hotta Y; Nakamura H; Konishi M; Murata Y; Takagi H; Matsumura S; Inoue K; Fushiki T; Itoh N
Endocrinology; 2009 Oct; 150(10):4625-33. PubMed ID: 19589869
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
[TBL] [Abstract][Full Text] [Related]
12. Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue.
Asrih M; Altirriba J; Rohner-Jeanrenaud F; Jornayvaz FR
PLoS One; 2015; 10(5):e0126364. PubMed ID: 25973847
[TBL] [Abstract][Full Text] [Related]
13. Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice.
So WY; Cheng Q; Xu A; Lam KS; Leung PS
Cell Death Dis; 2015 Mar; 6(3):e1707. PubMed ID: 25811804
[TBL] [Abstract][Full Text] [Related]
14. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
[TBL] [Abstract][Full Text] [Related]
16. Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice.
Maekawa R; Seino Y; Ogata H; Murase M; Iida A; Hosokawa K; Joo E; Harada N; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Hayashi Y; Arima H
J Nutr Biochem; 2017 Nov; 49():71-79. PubMed ID: 28886439
[TBL] [Abstract][Full Text] [Related]
17. Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice.
Kamimura N; Nishimaki K; Ohsawa I; Ohta S
Obesity (Silver Spring); 2011 Jul; 19(7):1396-403. PubMed ID: 21293445
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenergic receptors are critical for weight loss but not for other metabolic adaptations to the consumption of a ketogenic diet in male mice.
Douris N; Desai BN; Fisher FM; Cisu T; Fowler AJ; Zarebidaki E; Nguyen NLT; Morgan DA; Bartness TJ; Rahmouni K; Flier JS; Maratos-Flier E
Mol Metab; 2017 Aug; 6(8):854-862. PubMed ID: 28752049
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 21 and exercise-induced hepatic mitochondrial adaptations.
Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Thyfault JP; Rector RS
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(10):G832-43. PubMed ID: 27012775
[TBL] [Abstract][Full Text] [Related]
20. FGF21 Mediates the Thermogenic and Insulin-Sensitizing Effects of Dietary Methionine Restriction but Not Its Effects on Hepatic Lipid Metabolism.
Wanders D; Forney LA; Stone KP; Burk DH; Pierse A; Gettys TW
Diabetes; 2017 Apr; 66(4):858-867. PubMed ID: 28096260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]